Your privacy choices

Essential storage keeps the site working. With your permission, we also measure visits and interactions on public research pages using first-party analytics. Optional third-party analytics and advertising trackers are currently disabled.

Read our privacy policy
Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.

Shoulder Innovations, Inc.

SINYSE
Wall Street Score · overall investment38/100
$19.01USD+$0.26 (+1.39%)
Company website www.shoulderinnovations.com
Headquarters1535 Steele Avenue SW, Grand Rapids, MI, 49507, US
Financial statement currencyUSD · no FX conversion applied
Healthcare · Medical - Specialties
Price updated todayFinancials updated Oct 1, 2026
Price Chart$-1.38 (-6.77%)
2026-09-042026-09-092026-09-112026-09-152026-09-172026-09-212026-09-232026-09-252026-09-292026-10-02$16.80$17.85$18.90$19.95$21.00

Company & revenue

About Shoulder Innovations, Inc.

Who they are

Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B.

Detailed revenue, brand and relationship research has not yet been completed for SI.

Wall Street Score

Overall investment score · Quality, value, risk and opportunity

38

Poor

PoorElite

View category scores →

Company Quality

How good is the actual business—regardless of today’s stock price?

61

Fair

Financial Strength

54

Business Quality / Moat

100

Management

40

Growth Quality

78

Risk / Durability

0

Weak Company · Expensive Stock

Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.

Opportunity

Opportunity Score · How does the current price compare with estimated value?

38

Avoid

Based on current valuation, company quality, recent trends, and available market signals.

View score details →

Model Outlook

12-month model · What does the model think happens next?

54/100

Building Historical Record

Model Score 54/100 — estimates relative performance potential, distinct from WallStreetScore (company quality).

Probability unavailable — the model has not produced a calibrated probability yet.

Click for full breakdown →

WSS View

The quick read

WSS currently sees meaningful weaknesses in the company-strength profile.

At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.

The model outlook is currently moderate.

What we like
  • •Balance-sheet / debt profile scores strongly
  • •Asset quality scores strongly
What to watch
  • •Debt service risk
  • •Valuation is a weaker part of the current profile
  • •Revenue fundamentals are weak

Company-specific research

Questions worth answering for SI

Research inputs 100% complete

These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.

  • •Can SI maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
  • •How long can SI fund negative free cash flow using its current cash position before it may need more debt or new shares?
  • •How is SI likely to use its cash advantage: reinvestment, acquisitions, debt reduction, dividends or buybacks?
  • •What specifically needs to improve for SI to reach sustainable profitability?
  • •What future growth or profitability would be needed to justify SI's current valuation?
Debt service risk
Business analysis: 41 days ago · Fresh

Essential Investment Snapshot

Wall Street Score

38

0–100 · Weak

Opportunity Score

38

0–100 · Weak

Market Cap

$394.2M

P/E Ratio

-11.1

EPS

$-1.71

52-Week High

$24.60

52-Week Low

$10.92

Beta

-1.77

Analyst Target

$23.50

Shares Outstanding

20.6M

Total Revenue

$60.1M

Total Debt

$14.8M

Dividend

No current dividend

View dividend history

Liquidation Value / Share

$6.03

Estimated net asset value per share

Momentum & Volatility Signals

Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.

0–100 market signals
Momentum
51/ 100
+44 pts / 5d

Neutral / mixed momentum

5D +11.9% · 20D -6.8% · RSI 57 · Price vs 20D avg +3.4%
Volatility
29/ 100
+10 pts / 5d

Low movement

20D realized vol 37.1% · 60D 62.2% · Acceleration 0.60x
Momentum = Where is it going?

A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.

Volatility = How violently is it moving?

A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.

Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.

Notices for SI

Detected from reported data — verify before acting.

Debt service risk

Interest coverage is low (~-375.7x). Earnings may be strained to cover interest expense.

Community Sentiment

0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)

No personal call yet on SI.

What the Bulls Say

  • +Product opportunity: Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.

What the Bears Say

  • −Negative free cash flow may increase the need for outside financing and dilution.

Bull and bear cases summarize disclosed catalysts, growth opportunities and risks; they are not buy or sell recommendations.

Create a free account to make a call.

Scores

Click any score for full breakdown
Wall Street Score
Weak38/ 100
Weak (0–50)Fair (51–71)Strong (72+)

Poor

38

Tap for breakdown →

Strong

84

Debt Cost0.5%
Debt Reduction YoY-2.0%
Debt / Equity0.11x

Tap for breakdown →

Weak

41

Revenue YoY26.9%
Revenue CAGR56.7%
Net Margin-58.3%

Tap for breakdown →

Strong

71

Asset Growth YoY2.9%
Liquidation/Share$6.03
Net Assets/MCap0.35x

Tap for breakdown →

Poor

0

Earnings Yield-8.9%
Buyback Yield0.0%
Debt Cost0.5%

Tap for breakdown →

Weak

40

ROIC-22.9%
ROE-28.2%
ROA-23.0%

Tap for breakdown →

Elite

100

EPS Growth—
FCF/Share Growth—
Rev/Share Growth44.5%

Tap for breakdown →

Poor

0

Intrinsic Value—
Value Reference—
MOS—

Tap for breakdown →

Fair

61

Revenue41
Moat100
Valuation0

Tap for breakdown →

Poor

0

MOS %—
Value Reference—
Deep Discount Reference—

Tap for breakdown →

Poor

25

Interest Coverage-375.7x
ROIC-22.9%
FCF Yield-9.1%

Tap for breakdown →

Poor

38

Financial25
Valuation0
Debt84

Tap for breakdown →

Poor

30

Survival Years3.5 yrs
Current Ratio11.07x
FCF Margin-0.8%

Tap for breakdown →

Was this stock page easy to understand?

One click helps us improve the research experience. This is not tied to an investment decision.

Score Changes

2 historical score records available

Previous Score

33

Jul 24, 2026

Change

+4.5

points

Current Score

38

Oct 1, 2026

Category Changes

Revenue+5.3
Debt0
Assets+0.1
Capital0
Management+40.0
Moat0
Valuation0
Buffett+7.1

SI increased 4.5 points because Revenue improved by 5.3 points, Management improved by 40 points, Buffett improved by 7.1 points.

Positive Contributors

  • + Revenue improved by 5.3 points
  • + Management improved by 40 points
  • + Buffett improved by 7.1 points

Projected Score

Projected Score

40

Projected Change

+2.2%

Preliminary comparable-period financial changes suggest improvement of approximately 2.2 points. This is a projected estimate, not the official WallStreetScore.

Price vs. Value

Valuation unavailable

Current Price

$19.01

Intrinsic Value

—

Difference

—

Margin of Safety

—

Value Reference: —
Deep Discount Reference: —

Intrinsic value is not currently available for this stock, so valuation can't be calculated.

Related Companies

Medical - Specialties

BWAY

BrainsWay Ltd.

54Fair
$13.20View

STE

STERIS plc

47Weak
$208.54View

ALC

Alcon Inc.

35Poor
$63.76View

DRIO

DarioHealth Corp.

34Poor
$6.46View

ITOC

iTonic Holdings Ltd.

33Poor
$0.25View

WOK

WORK Medical Technology Group Ltd. Class A

29Poor
$1.76View

News

Defense World3d ago

Shoulder Innovations, Inc. (NYSE:SI) Stock Has Average Target Price of $25.50

Defense World14d ago

Squarepoint Ops LLC Invests $896,000 in Shoulder Innovations, Inc. $SI

Seeking Alpha17d ago

Shoulder Innovations, Inc. (SI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

PRNewsWire22d ago

Shoulder Innovations Receives FDA 510(k) Clearance for N-22 Humeral Head and Initiates Full Commercial Launch

Related Stock Research

Continue researching this company with related Wall Street Score rankings and investing guides.

Highest Wall Street Score stocksBest growth stocksBest healthcare stocksHow Wall Street Score worksHow to analyze a stockUnderstanding financial healthIntrinsic value guide

Score Alerts

Premium unlocks alerts when a score rises, falls, or reaches your target price.

Start 7-Day Free Trial

Portfolio Score

Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.

Start 7-Day Free Trial